Galderma Investigational Site

Waterloo ON N2J 1C4

0 studies enrolling now · 2 studies all time

What they study most

Acne Vulgaris, Atopic Dermatitis

Studies at this site

• Dose-ranging Study of Nemolizumab in Atopic Dermatitis — Completed
• Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris — Completed